FARAONI, ISABELLA
FARAONI, ISABELLA
Dipartimento di Medicina dei sistemi
A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro
2005-01-01 Faraoni, I; Cottarelli, A; Giuliani, A; Bonmassar, L; Rossi, L; Bonmassar, E
Abscopal effect and drug-induced xenogenization: a strategic alliance in cancer treatment?
2021-10-01 Franzese, O; Torino, F; Giannetti, E; Cioccoloni, G; Aquino, A; Faraoni, I; Fuggetta, Mp; De Vecchis, L; Giuliani, A; Kaina, B; Bonmassar, E
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies
2019-10-01 Noguera, Ni; Catalano, G; Banella, C; Divona, M; Faraoni, I; Ottone, T; Arcese, W; Voso, Mt
Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells
2000-08-01 D'Atri, S; Graziani, G; Lacal, P; Nisticò, V; Gilberti, S; Faraoni, I; Watson, A; Bonmassar, E; Margison, G
AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro
1997-01-01 Macchi, B; Faraoni, I; Zhang, J; Grelli, S; Favalli, C; Mastino, A; Bonmassar, E
BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib.
2015-03-01 Faraoni, I; Compagnone, M; Lavorgna, S; Angelini, D; Cencioni, M; Piras, E; Panetta, P; Ottone, T; DOLCI IANNINI, S; Venditti, A; Graziani, G; LO COCO, F
Clinical applications of telomerase in cancer treatment
2000-06-01 Faraoni, I; Bonmassar, E; Graziani, G
Comparative antiviral and antiproliferative activity of PGA1 and PGJ2 against HTLV-1-infected MT-2 cells.
1992-01-01 D'Onofrio, C; Amici, C; Puglianiello, A; Faraoni, I; Lanzilli, G; Santoro, Mg; Bonmassar, E
COMPARATIVE ANTIVIRAL AND ANTIPROLIFERATIVE ACTIVITY OF PGA1 AND PGJ2 AGAINST HTLV-I-INFECTED MT-2 CELLS
1992-01-01 D'Onofrio, C; Amici, C; Puglianiello, A; Faraoni, I; Lanzilli, G; Santoro, Mg; Bonmassar, E
Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes
2019-01-01 Faraoni, I; Consalvo, Mi; Aloisio, F; Fabiani, E; Giansanti, M; Di Cristino, F; Falconi, G; Tentori, L; Di Veroli, A; Curzi, P; Maurillo, L; Niscola, P; Lo-Coco, F; Graziani, G; Voso, Mt
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro
1997-04-01 Faraoni, I; Turriziani, M; Masci, G; DE VECCHIS, L; Shay, J; Bonmassar, E; Graziani, G
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro
1998-01-01 Faraoni, I; Turriziani, M; Masci, G; DE VECCHIS, L; Shay, J; Bonmassar, ; Graziani, G
Development of a novel in vitro chemosensitivity assay: telomerase as a possible marker of tumor cell survival
1996-10-01 Faraoni, I; Turriziani, M; Bonmasssar, E; DE VECCHIS, L; Graziani, G
Effect of beta interferon on HTLV I infection of fractionated T cells
1991-01-01 Macchi, B; Faraoni, I; Gentili, G; D'Onofrio, C; Bonmassar, E
Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications
2021-05-03 Kianmehr, A; Faraoni, I; Kucuk, O; Mahrooz, A
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line
2019-11-28 Cioccoloni, G; Aquino, A; Notarnicola, M; Caruso, Mg; Bonmassar, E; Zonfrillo, M; Caporali, S; Faraoni, I; Villiva, C; Fuggetta, Mp; Franzese, O
High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients
2021-03-20 Giansanti, M; Karimi, T; Faraoni, I; Graziani, G
HSP70 production and inhibition of cell proliferation in molt-4 T-cells after cell-to-cell transmission of HTLV-I: Effect of PGA1
1995-01-01 D(')Onofrio, C; Puglianiello, A; Amici, C; Faraoni, I; Lanzilli, G; Bonmassar, E
In vitro chemosensitivity of neoplastic cells: Telomerase as a possible marker of tumor cell survival
1996-01-01 Faraoni, I; Turriziani, M; De Vecchis, L; Laurenza, M; Macchini, V; Baliva, G; Bonmassar, E; Graziani, G
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype
1995-01-01 Giuliani, A; Vernole, P; D'Atri, S; DEL POETA, G; D'Onofrio, C; Faraoni, I; Greiner, J; Bonmassar, E; Graziani, G
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2005 | A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro | Faraoni, I; Cottarelli, A; Giuliani, A; Bonmassar, L; Rossi, L; Bonmassar, E | Articolo su rivista | |
| 1-ott-2021 | Abscopal effect and drug-induced xenogenization: a strategic alliance in cancer treatment? | Franzese, O; Torino, F; Giannetti, E; Cioccoloni, G; Aquino, A; Faraoni, I; Fuggetta, Mp; De Vecchis, L; Giuliani, A; Kaina, B; Bonmassar, E | Articolo su rivista | |
| 1-ott-2019 | Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies | Noguera, Ni; Catalano, G; Banella, C; Divona, M; Faraoni, I; Ottone, T; Arcese, W; Voso, Mt | Articolo su rivista | |
| 1-ago-2000 | Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells | D'Atri, S; Graziani, G; Lacal, P; Nisticò, V; Gilberti, S; Faraoni, I; Watson, A; Bonmassar, E; Margison, G | Articolo su rivista | |
| 1-gen-1997 | AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro | Macchi, B; Faraoni, I; Zhang, J; Grelli, S; Favalli, C; Mastino, A; Bonmassar, E | Articolo su rivista | |
| 1-mar-2015 | BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib. | Faraoni, I; Compagnone, M; Lavorgna, S; Angelini, D; Cencioni, M; Piras, E; Panetta, P; Ottone, T; DOLCI IANNINI, S; Venditti, A; Graziani, G; LO COCO, F | Articolo su rivista | |
| 1-giu-2000 | Clinical applications of telomerase in cancer treatment | Faraoni, I; Bonmassar, E; Graziani, G | Articolo su rivista | |
| 1-gen-1992 | Comparative antiviral and antiproliferative activity of PGA1 and PGJ2 against HTLV-1-infected MT-2 cells. | D'Onofrio, C; Amici, C; Puglianiello, A; Faraoni, I; Lanzilli, G; Santoro, Mg; Bonmassar, E | Articolo su rivista | |
| 1-gen-1992 | COMPARATIVE ANTIVIRAL AND ANTIPROLIFERATIVE ACTIVITY OF PGA1 AND PGJ2 AGAINST HTLV-I-INFECTED MT-2 CELLS | D'Onofrio, C; Amici, C; Puglianiello, A; Faraoni, I; Lanzilli, G; Santoro, Mg; Bonmassar, E | Intervento a convegno | |
| 1-gen-2019 | Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes | Faraoni, I; Consalvo, Mi; Aloisio, F; Fabiani, E; Giansanti, M; Di Cristino, F; Falconi, G; Tentori, L; Di Veroli, A; Curzi, P; Maurillo, L; Niscola, P; Lo-Coco, F; Graziani, G; Voso, Mt | Articolo su rivista | |
| 1-apr-1997 | Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro | Faraoni, I; Turriziani, M; Masci, G; DE VECCHIS, L; Shay, J; Bonmassar, E; Graziani, G | Articolo su rivista | |
| 1-gen-1998 | Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro | Faraoni, I; Turriziani, M; Masci, G; DE VECCHIS, L; Shay, J; Bonmassar, ; Graziani, G | Contributo in libro | |
| 1-ott-1996 | Development of a novel in vitro chemosensitivity assay: telomerase as a possible marker of tumor cell survival | Faraoni, I; Turriziani, M; Bonmasssar, E; DE VECCHIS, L; Graziani, G | Articolo su rivista | |
| 1-gen-1991 | Effect of beta interferon on HTLV I infection of fractionated T cells | Macchi, B; Faraoni, I; Gentili, G; D'Onofrio, C; Bonmassar, E | Articolo su rivista | |
| 3-mag-2021 | Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications | Kianmehr, A; Faraoni, I; Kucuk, O; Mahrooz, A | Articolo su rivista | |
| 28-nov-2019 | Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line | Cioccoloni, G; Aquino, A; Notarnicola, M; Caruso, Mg; Bonmassar, E; Zonfrillo, M; Caporali, S; Faraoni, I; Villiva, C; Fuggetta, Mp; Franzese, O | Articolo su rivista | |
| 20-mar-2021 | High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients | Giansanti, M; Karimi, T; Faraoni, I; Graziani, G | Articolo su rivista | |
| 1-gen-1995 | HSP70 production and inhibition of cell proliferation in molt-4 T-cells after cell-to-cell transmission of HTLV-I: Effect of PGA1 | D(')Onofrio, C; Puglianiello, A; Amici, C; Faraoni, I; Lanzilli, G; Bonmassar, E | Articolo su rivista | |
| 1-gen-1996 | In vitro chemosensitivity of neoplastic cells: Telomerase as a possible marker of tumor cell survival | Faraoni, I; Turriziani, M; De Vecchis, L; Laurenza, M; Macchini, V; Baliva, G; Bonmassar, E; Graziani, G | Articolo su rivista | |
| 1-gen-1995 | In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype | Giuliani, A; Vernole, P; D'Atri, S; DEL POETA, G; D'Onofrio, C; Faraoni, I; Greiner, J; Bonmassar, E; Graziani, G | Articolo su rivista |